HOME >> MEDICINE >> NEWS
ReQuip cuts risk of dyskinesias by 15-fold in early Parkinson's disease

Vancouver, Canada - A landmark, multinational, 5-year study shows that the dopamine-agonist ReQuip® (ropinirole hydrochloride, SmithKline Beecham) is associated with a much lower incidence of dyskinesias than L-dopa, and has comparable efficacy to L-dopa in the management of early Parkinson's Disease. The results of this exciting study are released today for the first time at the XIII International Congress on Parkinson's Disease (ICPD), Vancouver, 24-28 July, 1999.

"This landmark study should affect the future management of Parkinson's Disease. The data demonstrate that ropinirole is a first-line option for the initial treatment of early Parkinson's Disease," commented lead author of the study, Professor Olivier Rascol, Professor of Pharmacology at the Centre Hospitalier Universitaire, Toulouse, France.

"This is important news for patients, as we can now hope for good control of their symptoms with less risk of dyskinesias," concluded Dr Donald Calne, Chairman of the ICPD, and Director of the Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, Canada.

The 268 patients participating in this double-blind controlled study, conducted in Europe, Israel and Canada, were randomised to receive either ReQuip® or L-dopa -- the current standard therapy. Both treatment groups were allowed to receive supplementary L-dopa if required.

The study demonstrated that the probability (odds ratio) of developing dyskinesias was 3.8 times higher for patients receiving L-dopa (incidence 46%) than for patients receiving ReQuip®, either alone or with additional L-dopa (incidence 20%). In patients who completed the trial on ReQuip® alone, the benefit was found to be even greater, with the relative probability of dyskinesias 15.2 times higher in the L-dopa group (incidence 36%) than the ReQuip® group (incidence 5%).

Over the 5-year study period, both groups of patients experienced similar control of their symptoms. A
'"/>

Contact: Kate Davies (Vancouver)
alexa@meditech.co.uk
44-780-840-345
MediTech Media Ltd.
26-Jul-1999


Page: 1 2

Related medicine news :

1. Clozapine effective for controlling dyskinesias in people with severe Parkinsons
2. New marker for early diagnosis of kidney failure identified
3. English-speaking Hispanic youth more likely to have sex early
4. Inpatient smoking cessation counseling is associated with early differences in mortality
5. Study finds no reason for expectant mothers to shy away from early epidurals
6. No increase in C-sections when epidural analgesia given early in labor
7. Radiologists offer non-surgical treatment for early-stage liver cancer
8. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
9. A new method for early detection of disease outbreaks
10. UCLA study: Nearly a third of drug ads in medical journals contain no references for medical claims
11. Morbidly obese pay nearly twice as much for health care

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/2/2018)... ... September 02, 2018 , ... Eaton Hotel in ... The hotel itself, which opened this week, inspires creativity and innovation among its ... , Eaton Hotel DC currently features 209 hotel rooms, a wellness center, a ...
(Date:9/1/2018)... ... ... SignatureCare Emergency Center is looking to award their 2018 Fall Scholarship. The ... Get your applications in now as the deadline is approaching fast. (July 31) , ... medical student at Texas Southern University. Wu was inspired to go into the medical ...
(Date:9/1/2018)... AUSTIN, Texas (PRWEB) , ... September 01, 2018 ... ... health event proclaimed by the International Veterinary Academy of Pain Management (IVAPM) that ... Texas Veterinary Medical Association (TVMA) is partnering with IVAPM by educating pet owners ...
(Date:8/31/2018)... Mich. (PRWEB) , ... August 31, 2018 , ... ... provider, will host an Open House on Wednesday, September 12 from 1:00-3:00 pm. ... available in Grand Rapids, as well as tour the facility, meet our staff ...
(Date:8/31/2018)... ... August 31, 2018 , ... The social impact documentary ... CSUN Psychology Professor and NIH-funded researcher Luciana Lagana, aka Dr. Luciana, has ... the Action on Film International Film Festival, IndieFEST Film Awards, Shawna Shea Memorial Film ...
Breaking Medicine News(10 mins):
(Date:9/12/2018)... ... September 13, 2018 , ... ... Webinar**, Sept. 27, 2018 — 1:30 p.m. – 3:00 p.m. ET, http://info.fdanews.com/safety-reporting-in-global-clinical-trials ... reporting by as much as fifty percent. , This can be due ...
(Date:9/7/2018)... ... September 06, 2018 , ... This year, the California ... Award for his presentation of: IDEAL IMPLANT® - Seven-Year Clinical Trial Results at the ... paper again at the upcoming ASPS (American Society of Plastic Surgeons) meeting in Chicago ...
(Date:9/7/2018)... ... September 07, 2018 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... Name of the Creator and says the proof is undeniable. , Yisrayl scolds mainstream religions ... of the Creator’s Name. Yisrayl shows there is great meaning in the Name, and to ...
Breaking Medicine Technology:
Cached News: